Showing results (581-590 of 671) with videos related to
Sort By:
Pageof 68
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphomaKirill A Lyapichev, Sergio Piña-Oviedo, L Jeffrey Medeiros, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 9, 2023
Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 StudySanja Dacic, William D Travis, Jennifer M Giltnane, et al.Clinical and Translational Medicine|July 29, 2021
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trialRaquel Laza-Briviesca, Alberto Cruz-Bermúdez, Ernest Nadal, et al.Cancer Letters|June 18, 2026
Deep Learning of CT Imaging Predicts PD-L1 Expression and Immunotherapy Response in Metastatic NSCLC: A Multi-Center StudyAmgad Muneer, Eman Showkatian, Maliazurina B Saad, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2020
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung CancerTina Cascone, Boris Sepesi, Heather Y Lin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung CancerVassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.Nature Communications|December 7, 2021
The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristicsMing Tang, Hussein A Abbas, Marcelo V Negrao, et al.Cancer Discovery|September 13, 2022
The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung AdenocarcinomaDapeng Hao, Guangchun Han, Ansam Sinjab, et al.Nature Medicine|September 13, 2022
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trialJamie E Chaft, Filiz Oezkan, Mark G Kris, et al.Journal for Immunotherapy of Cancer|May 17, 2020
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validationJanis M Taube, Guray Akturk, Michael Angelo, et al.Pageof 68